Company Analysis Beauty Farm Medical and Health Industry Inc.
1. Summary
Advantages
- The company's current efficiency (ROE=47.47%) is higher than the sector average (ROE=4.33%)
Disadvantages
- Price (22.2 HK$) is higher than fair price (4.98 HK$)
- Dividends (5.27%) are below the sector average (5.6%).
- The stock's return over the last year (37.38%) is lower than the sector average (38.68%).
Similar companies
2. Share price and performance
2.1. Share price
2.3. Market efficiency
| Beauty Farm Medical and Health Industry Inc. | Healthcare | Index | |
|---|---|---|---|
| 7 days | -6.3% | 21.7% | -1.5% |
| 90 days | 32.9% | 16.7% | -0.7% |
| 1 year | 37.4% | 38.7% | 30.5% |
2373 vs Sector: Beauty Farm Medical and Health Industry Inc. has slightly underperformed the "Healthcare" sector by -1.3% over the past year.
2373 vs Market: Beauty Farm Medical and Health Industry Inc. has outperformed the market by 6.86% over the past year.
Stable price: 2373 is not significantly more volatile than the rest of the market on "Hong Kong Exchanges" over the last 3 months, with typical variations of +/- 5% per week.
Long period: 2373 with weekly volatility of 0.7188% over the past year.
3. Summary of the report
4. Fundamental Analysis
4.1. Stock price and price forecast
Above fair price: The current price (22.2 HK$) is higher than the fair price (4.98 HK$).
Price is higher than fair: The current price (22.2 HK$) is 77.6% higher than the fair price.
4.2. P/E
P/E vs Sector: The company's P/E (38.21) is higher than that of the sector as a whole (31.87).
P/E vs Market: The company's P/E (38.21) is lower than that of the market as a whole (44.35).
4.2.1 P/E Similar companies
4.3. P/BV
P/BV vs Sector: The company's P/BV (21.4) is higher than that of the sector as a whole (2.54).
P/BV vs Market: The company's P/BV (21.4) is higher than that of the market as a whole (1.59).
4.3.1 P/BV Similar companies
4.4. P/S
P/S vs Sector: The company's P/S indicator (2.41) is lower than that of the sector as a whole (6.25).
P/S vs Market: The company's P/S indicator (2.41) is lower than that of the market as a whole (2.64).
4.4.1 P/S Similar companies
4.5. EV/Ebitda
EV/Ebitda vs Sector: The company's EV/Ebitda (8.75) is higher than that of the sector as a whole (2.91).
EV/Ebitda vs Market: The company's EV/Ebitda (8.75) is lower than that of the market as a whole (9.93).
5. Profitability
5.1. Profitability and revenue
5.2. Earnings per share - EPS
5.3. Past profitability Net Income
Yield Trend: Negative and has fallen by -6.34% over the last 5 years.
Accelerating profitability: The return for the last year (0%) exceeds the average return for 5 years (-6.34%).
Profitability vs Sector: The return for the last year (0%) exceeds the return for the sector (-1.23%).
5.4. ROE
ROE vs Sector: The company's ROE (47.47%) is higher than that of the sector as a whole (4.33%).
ROE vs Market: The company's ROE (47.47%) is higher than that of the market as a whole (2.87%).
5.5. ROA
ROA vs Sector: The company's ROA (3.41%) is higher than that of the sector as a whole (3.29%).
ROA vs Market: The company's ROA (3.41%) is higher than that of the market as a whole (3.12%).
5.6. ROIC
ROIC vs Sector: The company's ROIC (0%) is lower than that of the sector as a whole (0%).
ROIC vs Market: The company's ROIC (0%) is lower than that of the market as a whole (20.88%).
7. Dividends
7.1. Dividend yield vs Market
Low yield: The dividend yield of the company 5.27% is below the average for the sector '5.6%.
7.2. Stability and increase in payments
Dividend stability: The company's dividend yield 5.27% has been steadily paid over the past 7 years, DSI=1.
Weak dividend growth: The company's dividend yield 5.27% has been growing weakly or stagnant over the past 5 years. Growth over only 2 years.
7.3. Payout percentage
Dividend Coverage: Current payments from income (0%) are at an uncomfortable level.
Pay for your subscription
More functionality and data for company and portfolio analysis is available by subscription
